Amyloid PET Radiopharmaceuticals and Imaging for Clinical and Research Applications in Thailand

In the past two decades, the research community has focused on defining reliable molecular biomarkers for the early diagnosis of Alzheimer's disease (AD). Several PET radiopharmaceuticals have been developed and gained regulatory approval for the non-invasive detection of Aβ amyloid deposits i...

書誌詳細
出版年:	Siriraj Medical Journal
主要な著者:	Tossaporn Siriprapa, Tanyaluck Thientunyakit, Juri Gelovani
フォーマット:	論文
言語:	英語
出版事項:	Faculty of Medicine Siriraj Hospital 2023-09-01
主題:	Amyloid PET radiopharmaceuticals Alzheimer’s disease Amyloid beta plaque (Aβ) Molecular imaging Dementia amyloid deposition
オンライン･アクセス:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/263161

類似資料

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
著者:: Poul F. Høilund-Carlsen, 等
出版事項: (2023-07-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
著者:: Shizuo Hatashita, 等
出版事項: (2019-09-01)

Human in vivo evidence of associations between herpes simplex virus and cerebral amyloid-beta load in normal aging
著者:: Jose L. Cantero, 等
出版事項: (2024-04-01)

Validation of 3‐ and 5‐point severity scales to assess ARIA‐E
著者:: Luc Bracoud, 等
出版事項: (2023-10-01)

Sleep duration, sleep efficiency, and amyloid β among cognitively healthy later-life adults: a systematic review and meta-analysis
著者:: Chooza Moon, 等
出版事項: (2024-05-01)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
著者:: George Tetz, 等
出版事項: (2021-06-01)

Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
著者:: Alexandra Wicker, 等
出版事項: (2024-10-01)

Plasma p‐tau217 concordance with amyloid PET among ethnically diverse older adults
著者:: Breton M. Asken, 等
出版事項: (2024-07-01)

Amyloid-β Peptide-targeting Immunotherapy in Alzheimer Disease: A Systematic Review of Clinical Studies
著者:: Haideh Mosleh, 等
出版事項: (2024-10-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
著者:: Rola Ismail, 等
出版事項: (2020-05-01)

Comparative study of 18F-labeled PET radiopharmaceuticals in an Alzheimer’s disease mouse model
著者:: Bok-Nam Park, 等
出版事項: (2025-08-01)

Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls
著者:: Ulf Jensen‐Kondering, 等
出版事項: (2025-08-01)

ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
著者:: Gillian Bonvicini, 等
出版事項: (2022-12-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
著者:: Sajjad Molavipordanjani, 等
出版事項: (2023-11-01)

Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with Dementia
著者:: Damiano Librizzi, 等
出版事項: (2021-02-01)

Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region
著者:: Giavanna Paterno, 等
出版事項: (2024-08-01)

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
著者:: Sha Sha, 等
出版事項: (2026-02-01)

Reliability of Automated Amyloid PET Quantification: Real-World Validation of Commercial Tools Against Centiloid Project Method
著者:: Yeon-koo Kang, 等
出版事項: (2025-07-01)

Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
著者:: María Pagnon de la Vega, 等
出版事項: (2024-02-01)

Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
著者:: Jihye Hwang, 等
出版事項: (2021-09-01)

Comparison of Amyloid-PET Analysis Software Using <sup>18</sup>F-Florbetaben PET in Patients with Cognitive Impairment
著者:: Miju Cheon, 等
出版事項: (2025-08-01)

Accounting for white matter uptake improves between tracer agreement in amyloid PET
著者:: Yinghua Chen, 等
出版事項: (2025-07-01)

Association between focal amyloid deposition and cognitive impairment in individuals below the amyloid threshold
著者:: Hongki Ham, 等
出版事項: (2024-10-01)

Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part A: Endogenous Compounds and Repurposed Drugs
著者:: Mariyana Atanasova
出版事項: (2025-02-01)

Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
著者:: Chae Jung Park, 等
出版事項: (2022-09-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
著者:: Xue-mei Qi, 等
出版事項: (2017-08-01)

Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development
著者:: Rouen Brockmann, 等
出版事項: (2023-04-01)

Icaritin, an inhibitor of beta-site amyloid cleaving enzyme-1, inhibits secretion of amyloid precursor protein in APP-PS1-HEK293 cells by impeding the amyloidogenic pathway
著者:: Fei Feng, 等
出版事項: (2019-12-01)

Aging and Progression of Beta-Amyloid Pathology in Alzheimer’s Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression
著者:: Cristina Fernández-Mendívil, 等
出版事項: (2020-07-01)

Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer’s patients
著者:: YoungSoon Yang, 等
出版事項: (2025-03-01)

Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part B: Natural Compounds
著者:: Mariyana Atanasova
出版事項: (2025-09-01)

Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population
著者:: Bo-Hyun Kim, 等
出版事項: (2023-10-01)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
著者:: Ikumi Tomizawa, 等
出版事項: (2022-06-01)

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
著者:: Anniina Snellman, 等
出版事項: (2023-04-01)

How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment — a bidding game experiment
著者:: I. S. van Maurik, 等
出版事項: (2023-11-01)

Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
著者:: Ariane Bollack, 等
出版事項: (2023-10-01)

White Button Mushroom (<i>Agaricus bisporus)</i> Supplementation Ameliorates Spatial Memory Deficits and Plaque Formation in an Amyloid Precursor Protein Mouse Model of Alzheimer’s Disease
著者:: Thalia T. Dimopoulos, 等
出版事項: (2022-10-01)

Mechanistic insights into the role of amyloid-β in innate immunity
著者:: Tatum Prosswimmer, 等
出版事項: (2024-03-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
著者:: Caterina Motta, 等
出版事項: (2023-08-01)

In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity
著者:: Samir Kumar-Singh, 等
出版事項: (2002-11-01)